Silmitasertib Completed Phase 1 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT05817708A Study of Silmitasertib (CX-4945) in Healthy Subject